OUTCOMES AND TOXICITY PROFILE IN ELDERLY DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS (DLBCL): A REAL-WORLD AND COMPARATIVE STUDY INVOLVING THREE DIFFERENT DOSE-MODULATED ANTHRACYCLINE-BASED IMMUNOCHEMOTHERAPY REGIMENS IN LATAM
LAPC Lage, RN Vita, CO Reichert, HF Culler, FA Freitas, LBO Alves, V Rocha, SAC Siqueira, RO Costa, J Pereira
Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil
Lido
485
Vezesque se leu este artigo
154
Total PDF
331
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 25 | 13 | 38 |
| 2025 5 | 56 | 12 | 68 |
| 2025 4 | 38 | 13 | 51 |
| 2025 3 | 57 | 6 | 63 |
| 2025 2 | 38 | 26 | 64 |
| 2025 1 | 35 | 12 | 47 |
| 2024 12 | 22 | 20 | 42 |
| 2024 11 | 35 | 33 | 68 |
| 2024 10 | 25 | 19 | 44 |
